| 1 |
Guo Y, Tan EK, Syn NL, Krishnamoorthy TL, Tan CK, Lim R, Lee SY, Chan CY, Cheow PC, Chung AYF, Jeyaraj PR, Goh BKP. Repeat liver resection vs salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis. Ann Hepatobiliary Pancreat Surg. 2019;23:305-312. [PMID: 31824994 DOI: 10.14701/ahbps.2019.23.4.305] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 2 |
Tan EK, Tan BK, Fong HC, Chua D, Chew KY, Koh YX, Chung AY, Lee SY, Teo JY, Cheow PC, Chan CY, Goh BK, Jeyaraj PR. Impact of Microsurgical Anastomosis of Hepatic Artery on Arterial Complications and Survival Outcomes After Liver Transplantation. Transplant Proc 2021;53:65-72. [PMID: 32951861 DOI: 10.1016/j.transproceed.2020.08.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Guo Y, Chua DW, Koh Y, Lee S, Cheow P, Kam J, Teo J, Chow PK, Chung AY, Ooi LL, Chan C, Goh BKP. Preoperative Predictors Including the Role of Inflammatory Indices in Predicting Early Recurrence After Re-resection for Recurrent Hepatocellular Carcinoma. World J Surg 2019;43:2587-94. [DOI: 10.1007/s00268-019-05051-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 4 |
Li J, Yang X, Huang L, Zhu X, Qiu M, Yan J, Yan Y, Wei S. Treatment Strategy for Post-hepatectomy Recurrent Hepatocellular Carcinoma Within the Milan Criteria: Repeat Resection, Local Ablative Therapy or Transarterial Chemoembolization? Indian J Surg. [DOI: 10.1007/s12262-022-03343-1] [Reference Citation Analysis]
|
| 5 |
Guerrini GP, Esposito G, Olivieri T, Magistri P, Ballarin R, Di Sandro S, Di Benedetto F. Salvage versus Primary Liver Transplantation for Hepatocellular Carcinoma: A Twenty-Year Experience Meta-Analysis. Cancers (Basel) 2022;14:3465. [PMID: 35884526 DOI: 10.3390/cancers14143465] [Reference Citation Analysis]
|
| 6 |
Tan HL, Goh BKP. Management of recurrent hepatocellular carcinoma after resection. Hepatobiliary Surg Nutr 2020;9:780-3. [PMID: 33299834 DOI: 10.21037/hbsn.2020.03.07] [Reference Citation Analysis]
|
| 7 |
Linn YL, Chee MY, Koh YX, Teo JY, Cheow PC, Chow PKH, Chan CY, Chung AYF, Ooi LLPJ, Goh BKP. Actual 10-year survivors and 10-year recurrence free survivors after primary liver resection for hepatocellular carcinoma in the 21st century: A single institution contemporary experience. J Surg Oncol 2021;123:214-21. [PMID: 33095920 DOI: 10.1002/jso.26259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
